The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792
Self-citationDemonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity
Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., & Welsh, M. J. (1991) · Science · doi:10.1126/science.1712984 · Cited by 1,137
Self-citationBear, C. E., Li, C., Kartner, N., Bridges, R. J., Jensen, T. J., Ramjeesingh, M., & Riordan, J. R. (1992) · Cell · doi:10.1016/0092-8674(92)90155-6 · Cited by 945
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E., & Welsh, M. J. (1990) · Nature · doi:10.1038/347358a0 · Cited by 708
Self-citation
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
Self-citationDegradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999
Cystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
Glycosidase inhibitors: update and perspectives on practical use
Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 715
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Hebert, D. N., & Molinari, M. (2007) · Physiological Reviews · doi:10.1152/physrev.00050.2006 · Cited by 671
CYSTIC FIBROSIS: GENOTYPIC AND PHENOTYPIC VARIATIONS
Zielenski, J., & Tsui, L.-C. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.004021 · Cited by 631
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., Canny, S., Du, K., Lukacs, G. L., & Caplan, M. J. (2004) · Science · doi:10.1126/science.1093941 · Cited by 562
Pedemonte, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24898 · Cited by 538
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Defective protein folding as a basis of human disease
Thomas, P. J., Qu, B.-H., & Pedersen, P. L. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89100-8 · Cited by 529
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Clancy, J. P., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., Ashlock, M. A., Ballmann, M., Boyle, M. P., Bronsveld, I., Campbell, P. W., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200393 · Cited by 515
Van Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 512
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495
Ward, C. L., & Kopito, R. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47306-1 · Cited by 486
Chloride channels as drug targets
Verkman, A. S., & Galietta, L. J. V. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2780 · Cited by 469
Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties
Sheppard, D. N., Rich, D. P., Ostedgaard, L. S., Gregory, R. J., Smith, A. E., & Welsh, M. J. (1993) · Nature · doi:10.1038/362160a0 · Cited by 467
Self-citationThe Cystic Fibrosis Transmembrane Conductance Regulator
Riordan, J. R. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.003141 · Cited by 446
Younger, J. M., Chen, L., Ren, H.-Y., Rosser, M. F. N., Turnbull, E. L., Fan, C.-Y., Patterson, C., & Cyr, D. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.041 · Cited by 440
Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections
Pier, G. B., Grout, M., Zaidi, T. S., Olsen, J. C., Johnson, L. G., Yankaskas, J. R., & Goldberg, J. B. (1996) · Science · doi:10.1126/science.271.5245.64 · Cited by 440
Quality Control and Protein Folding in the Secretory Pathway
Trombetta, E. S., & Parodi, A. J. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.110701.153949 · Cited by 422
Protein‐misfolding diseases and chaperone‐based therapeutic approaches
Chaudhuri, T. K., & Paul, S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05181.x · Cited by 419
Guerriero, C. J., & Brodsky, J. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00027.2011 · Cited by 418
Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis
GRUBB, B. R., & BOUCHER, R. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s193 · Cited by 410
Biosynthesis and Degradation of CFTR
KOPITO, R. R. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s167 · Cited by 410
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Okiyoneda, T., Barrière, H., Bagdány, M., Rabeh, W. M., Du, K., Höhfeld, J., Young, J. C., & Lukacs, G. L. (2010) · Science · doi:10.1126/science.1191542 · Cited by 408
Physiological Basis of Cystic Fibrosis: A Historical Perspective
QUINTON, P. M. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s3 · Cited by 405
The spectrum of cystic fibrosis mutations
Tsui, L.-C. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90301-j · Cited by 404
Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., & Grinstein, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06954.x · Cited by 396
Villella, V. R., Esposito, S., Bruscia, E. M., Maiuri, M. C., Raia, V., Kroemer, G., & Maiuri, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00001 · Cited by 389
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Lukacs, G. L., Chang, X. B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R., & Grinstein, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80582-1 · Cited by 387
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Okiyoneda, T., Veit, G., Dekkers, J. F., Bagdany, M., Soya, N., Xu, H., Roldan, A., Verkman, A. S., Kurth, M., Simon, A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1253 · Cited by 378
CFTR: folding, misfolding and correcting the ΔF508 conformational defect
Lukacs, G. L., & Verkman, A. S. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.003 · Cited by 375
Pind, S., Riordan, J. R., & Williams, D. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99944-8 · Cited by 357
Du, K., Sharma, M., & Lukacs, G. L. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb882 · Cited by 356
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel.
Reisin, I. L., Prat, A. G., Abraham, E. H., Amara, J. F., Gregory, R. J., Ausiello, D. A., & Cantiello, H. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32033-1 · Cited by 355
Self-citationSalmonella typhi uses CFTR to enter intestinal epithelial cells
Pier, G. B., Grout, M., Zaidi, T., Meluleni, G., Mueschenborn, S. S., Banting, G., Ratcliff, R., Evans, M. J., & Colledge, W. H. (1998) · Nature · doi:10.1038/30006 · Cited by 342
RUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation
Flume, P. A., Liou, T. G., Borowitz, D. S., Li, H., Yen, K., Ordoñez, C. L., & Geller, D. E. (2012) · Chest · doi:10.1378/chest.11-2672 · Cited by 338
Yang, Y., Janich, S., Cohn, J. A., & Wilson, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9480 · Cited by 337
The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis
Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., & Cyr, D. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1492 · Cited by 335
Hamra, F. K., Forte, L. R., Eber, S. L., Pidhorodeckyj, N. V., Krause, W. J., Freeman, R. H., Chin, D. T., Tompkins, J. A., Fok, K. F., & Smith, C. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10464 · Cited by 335
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
Ron, I., & Horowitz, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi240 · Cited by 330
Tamarappoo, B. K., & Verkman, A. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2303 · Cited by 329
Misfolding diverts CFTR from recycling to degradation
Sharma, M., Pampinella, F., Nemes, C., Benharouga, M., So, J., Du, K., Bache, K. G., Papsin, B., Zerangue, N., Stenmark, H., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312018 · Cited by 329
Rescue of ΔF508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway
Gee, H. Y., Noh, S. H., Tang, B. L., Kim, K. H., & Lee, M. G. (2011) · Cell · doi:10.1016/j.cell.2011.07.021 · Cited by 328
DiMango, E., Ratner, A. J., Bryan, R., Tabibi, S., & Prince, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2865 · Cited by 323
Kölling, R., & Hollenberg, C. P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06627.x · Cited by 319
Rogers, C. S., Hao, Y., Rokhlina, T., Samuel, M., Stoltz, D. A., Li, Y., Petroff, E., Vermeer, D. W., Kabel, A. C., Yan, Z., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34773 · Cited by 319
Self-citationEckford, P. D. W., Li, C., Ramjeesingh, M., & Bear, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393637 · Cited by 309
A mouse model for the delta F508 allele of cystic fibrosis.
Zeiher, B. G., Eichwald, E., Zabner, J., Smith, J. J., Puga, A. P., McCray, P. B., Capecchi, M. R., Welsh, M. J., & Thomas, K. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118253 · Cited by 298
Self-citationBerry, V., Francis, P., Kaushal, S., Moore, A., & Bhattacharya, S. (2000) · Nature Genetics · doi:10.1038/75538 · Cited by 287
Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?
Willis, M. S., & Patterson, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1106180 · Cited by 284
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Pharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283
Pharmacology of CFTR Chloride Channel Activity
SCHULTZ, B. D., SINGH, A. K., DEVOR, D. C., & BRIDGES, R. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s109 · Cited by 282
Rabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., di Bernardo, S., Liu, Y., Konermann, L., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.024 · Cited by 280
Zhang, Y., Nijbroek, G., Sullivan, M. L., McCracken, A. A., Watkins, S. C., Michaelis, S., & Brodsky, J. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1303 · Cited by 277
Rubenstein, R. C., & Zeitlin, P. L. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.2.c259 · Cited by 269
Lewis, H. A., Zhao, X., Wang, C., Sauder, J. M., Rooney, I., Noland, B. W., Lorimer, D., Kearins, M. C., Conners, K., Condon, B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410968200 · Cited by 269
ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis
Kälin, N., Claaß, A., Sommer, M., Puchelle, E., & Tümmler, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5731 · Cited by 266
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences
Mendoza, J. L., Schmidt, A., Li, Q., Nuvaga, E., Barrett, T., Bridges, R. J., Feranchak, A. P., Brautigam, C. A., & Thomas, P. J. (2012) · Cell · doi:10.1016/j.cell.2011.11.023 · Cited by 261
∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis
Pankow, S., Bamberger, C., Calzolari, D., Martínez-Bartolomé, S., Lavallée-Adam, M., Balch, W. E., & Yates, J. R. (2015) · Nature · doi:10.1038/nature15729 · Cited by 258
Halaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V., & Hebert, D. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6210 · Cited by 257
Ulloa‐Aguirre, A., Janovick, J. A., Brothers, S. P., & Conn, P. M. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00232.x · Cited by 253
Disorder-associated mutations lead to functional inactivation of neuroligins
Chih, B., Afridi, S. K., Clark, L., & Scheiffele, P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh158 · Cited by 242
Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M. O., Akhmanova, A., Jaarsma, D., & Hoogenraad, C. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2661-07.2007 · Cited by 239
Correcting temperature-sensitive protein folding defects
Brown, C. R., Hong-Brown, L. Q., & Welch, W. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119302 · Cited by 176
Govoni, G., Vidal, S., Gauthier, S., Skamene, E., Malo, D., & Gros, P. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.2923-2929.1996 · Cited by 167
Functional Characterization of Candida albicans ABC Transporter Cdr1p
Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S. V., & Prasad, R. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1361-1375.2003 · Cited by 135
Kawaguchi, R., Yu, J., Wiita, P., Honda, J., & Sun, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801060200 · Cited by 70
Sendai virus-mediated CFTR gene transfer to the airway epithelium
Ferrari, S., Griesenbach, U., Iida, A., Farley, R., Wright, A. M., Zhu, J., Munkonge, F. M., Smith, S. N., You, J., Ban, H., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302991 · Cited by 63
Proctor, E. A., Kota, P., Aleksandrov, A. A., He, L., Riordan, J. R., & Dokholyan, N. V. (2015) · Chemical Science · doi:10.1039/c4sc01320d · Cited by 61
Dysfunction of CFTR bearing the AF508 mutation
Welsh, M. J., Denning, G. M., Ostedgaard, L. S., & Anderson, M. P. (1993) · Journal of Cell Science · doi:10.1242/jcs.1993.supplement_17.33 · Cited by 47
Self-citationBenchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants
McDonald, E. F., Oliver, K. E., Schlebach, J. P., Meiler, J., & Plate, L. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297560 · Cited by 39
Salazar, M. D., Zelt, N. B., Saldivar, R., Kuntz, C. P., Chen, S., Penn, W. D., Bonneau, R., Koehler Leman, J., & Schlebach, J. P. (2020) · Biochemistry · doi:10.1021/acs.biochem.9b00956 · Cited by 25
Metadata
- Authors
- Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J.
- Venue
- Nature
- Published
- 1992-08
- Volume
- 358
- Issue
- 6389
- Pages
- 761-764
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2079234445
- Cited by
- 1,234
- References
- 22
- FWCI
- 42.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.